These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24989076)

  • 1. Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.
    Mantere T; Haanpää M; Hanenberg H; Schleutker J; Kallioniemi A; Kähkönen M; Parto K; Avela K; Aittomäki K; von Koskull H; Hartikainen JM; Kosma VM; Laasanen SL; Mannermaa A; Pylkäs K; Winqvist R
    Clin Genet; 2015 Jul; 88(1):68-73. PubMed ID: 24989076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.
    Barroso E; Pita G; Arias JI; Menendez P; Zamora P; Blanco M; Benitez J; Ribas G
    Breast Cancer Res Treat; 2009 Dec; 118(3):655-60. PubMed ID: 19536649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
    Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
    Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
    Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
    Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FANCA and FANCG are the major Fanconi anemia genes in the Korean population.
    Park J; Chung NG; Chae H; Kim M; Lee S; Kim Y; Lee JW; Cho B; Jeong DC; Park IY
    Clin Genet; 2013 Sep; 84(3):271-5. PubMed ID: 23067021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of Fanconi anemia mutations in China.
    Li N; Ding L; Li B; Wang J; D'Andrea AD; Chen J
    Exp Hematol; 2018 Oct; 66():32-41.e8. PubMed ID: 30031030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
    Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
    Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe telomere shortening in Fanconi anemia complementation group L.
    Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
    Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia.
    Doubaj Y; Zrhidri A; Elalaoui SC; Lyahyai J; El Kadiri Y; Elkassimi N; Sbiti A; El Kababri M; Hessissen L; Sefiani A
    Pan Afr Med J; 2021; 39():72. PubMed ID: 34422195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
    Alter BP; Best AF
    Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
    Lakhi NA; Mizejewski GJ
    Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi anemia founder mutation in Macedonian patients.
    Madjunkova S; Kocheva SA; Plaseska-Karanfilska D
    Acta Haematol; 2014; 132(1):15-21. PubMed ID: 24356203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.